12 Health Care Stocks Moving In Thursday's After-Market Session

週四盤後交易時段，12只醫療保健股走勢

Benzinga Real-time News · 2022/04/15 05:50

Kaleido Biosciences (NASDAQ:KLDO) stock increased by 10.3% to $0.32 during Thursday's after-market session. Today's trading volume for this security ended up closing at 14.2 million shares, which is 369.4 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $13.6 million.
NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares moved upwards by 9.28% to $0.95. At the close, NeuroBo Pharmaceuticals's trading volume reached 232.9K shares. This is 119.9% of its average volume over the last 100 days. The company's market cap stands at $25.3 million.
ASLAN Pharma (NASDAQ:ASLN) shares rose 9.14% to $0.82. The market value of their outstanding shares is at $57.1 million.
Renalytix (NASDAQ:RNLX) stock moved upwards by 7.87% to $6.3. The company's market cap stands at $235.4 million.
Calyxt (NASDAQ:CLXT) stock rose 6.06% to $0.7. The company's market cap stands at $29.9 million.
aTyr Pharma (NASDAQ:LIFE) shares increased by 6.06% to $5.25. The market value of their outstanding shares is at $145.9 million.

Nektar Therapeutics (NASDAQ:NKTR) shares fell 22.1% to $4.8 during Thursday's after-market session. Nektar Therapeutics's trading volume hit 1.3 million shares by close, accounting for 41.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $894.1 million.
InVivo Therapeutics Hldg (NASDAQ:NVIV) stock declined by 8.95% to $0.27. This security traded at a volume of 80.1K shares come close, making up 15.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $9.4 million.
Evoke Pharma (NASDAQ:EVOK) stock fell 8.36% to $0.35. The market value of their outstanding shares is at $11.6 million.
Avenue Therapeutics (NASDAQ:ATXI) stock declined by 6.64% to $0.47. The company's market cap stands at $10.3 million.
Galectin Therapeutics (NASDAQ:GALT) shares declined by 6.33% to $1.63. This security traded at a volume of 519.1K shares come close, making up 525.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $96.7 million.
Immunogen (NASDAQ:IMGN) shares decreased by 5.43% to $5.06. The company's market cap stands at $1.1 billion. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Kaleido Biosciences (NASDAQ:KLDO) stock increased by 10.3% to $0.32 during Thursday's after-market session. Today's trading volume for this security ended up closing at 14.2 million shares, which is 369.4 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $13.6 million.
NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares moved upwards by 9.28% to $0.95. At the close, NeuroBo Pharmaceuticals's trading volume reached 232.9K shares. This is 119.9% of its average volume over the last 100 days. The company's market cap stands at $25.3 million.
ASLAN Pharma (NASDAQ:ASLN) shares rose 9.14% to $0.82. The market value of their outstanding shares is at $57.1 million.
Renalytix (NASDAQ:RNLX) stock moved upwards by 7.87% to $6.3. The company's market cap stands at $235.4 million.
Calyxt (NASDAQ:CLXT) stock rose 6.06% to $0.7. The company's market cap stands at $29.9 million.
aTyr Pharma (NASDAQ:LIFE) shares increased by 6.06% to $5.25. The market value of their outstanding shares is at $145.9 million.

卡萊多生物科學納斯達克(KLDO：KLDO)股價週四盤後上漲10.3%，至0.32美元。該證券今日成交量為1,420萬股，是過去100日平均成交量的369.4%。他們流通股的市值為1360萬美元。
NeuroBo製藥納斯達克(Sequoia Capital：NRBO)股價上漲9.28%至0.95美元。收盤時，NeuroBo製藥的成交量達到232.9萬股。這是過去100日平均成交量的119.9。該公司的市值為2530萬美元。
阿斯蘭製藥公司納斯達克(Sequoia Capital：ASLN)股價上漲9.14%，至0.82美元。他們流通股的市值為5710萬美元。
Renalytix納斯達克(Tmall：RNLX)股價上漲7.87%，至6.3美元。該公司的市值為2.354億美元。
Calyxt納斯達克(Tmall：CLXT)股價上漲6.06%，至0.7美元。該公司的市值為2990萬美元。
阿泰爾製藥公司納斯達克：LIFE)股價上漲6.06%，至5.25美元。他們流通股的市值為1.459億美元。

Nektar Therapeutics (NASDAQ:NKTR) shares fell 22.1% to $4.8 during Thursday's after-market session. Nektar Therapeutics's trading volume hit 1.3 million shares by close, accounting for 41.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $894.1 million.
InVivo Therapeutics Hldg (NASDAQ:NVIV) stock declined by 8.95% to $0.27. This security traded at a volume of 80.1K shares come close, making up 15.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $9.4 million.
Evoke Pharma (NASDAQ:EVOK) stock fell 8.36% to $0.35. The market value of their outstanding shares is at $11.6 million.
Avenue Therapeutics (NASDAQ:ATXI) stock declined by 6.64% to $0.47. The company's market cap stands at $10.3 million.
Galectin Therapeutics (NASDAQ:GALT) shares declined by 6.33% to $1.63. This security traded at a volume of 519.1K shares come close, making up 525.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $96.7 million.
Immunogen (NASDAQ:IMGN) shares decreased by 5.43% to $5.06. The company's market cap stands at $1.1 billion. See Also:

Nektar治療公司納斯達克股價週四盤後下跌22.1%，至4.8美元。截至收盤，Nektar Treateutics的成交量達到130萬股，佔其過去100天平均成交量的41.9%。他們流通股的市值為8.941億美元。
體內治療Hldg納斯達克股價下跌8.95%，至0.27美元。這只證券的成交量為80.1K股，接近於過去100天平均成交量的15.6%。他們流通股的市值為940萬美元。
喚起藥業納斯達克：EVOK)股價下跌8.36%，至0.35美元。他們流通股的市值為1160萬美元。
大道治療公司納斯達克(Tmall：ATXI)股價下跌6.64%，至0.47美元。該公司的市值為1,030萬美元。
Galectin治療藥物納斯達克股票代碼：GALT)股價下跌6.33%，至1.63美元。這只證券的成交量為519.1K股，接近於過去100日平均成交量的525.0%。他們流通股的市值為9670萬美元。
免疫基因納斯達克(Tmall：IMGN)股價下跌5.43%，至5.06美元。該公司的市值為11億美元。另見：

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由benzinga的自動內容引擎生成，並由編輯審閱.

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。

風險及免責聲明